Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Investigations into the mechanism of action of sublancin.

Wu C, Biswas S, Garcia De Gonzalo CV, van der Donk WA.

ACS Infect Dis. 2018 Dec 24. doi: 10.1021/acsinfecdis.8b00320. [Epub ahead of print]

PMID:
30582697
2.

Structure-Activity Relationships of the S-Linked Glycocin Sublancin.

Biswas S, Garcia De Gonzalo CV, Repka LM, van der Donk WA.

ACS Chem Biol. 2017 Dec 15;12(12):2965-2969. doi: 10.1021/acschembio.7b00819. Epub 2017 Nov 10.

3.

The phosphoenolpyruvate:sugar phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin.

Garcia De Gonzalo CV, Denham EL, Mars RA, St├╝lke J, van der Donk WA, van Dijl JM.

Antimicrob Agents Chemother. 2015 Nov;59(11):6844-54. doi: 10.1128/AAC.01519-15. Epub 2015 Aug 17.

4.

NMR structure of the S-linked glycopeptide sublancin 168.

Garcia De Gonzalo CV, Zhu L, Oman TJ, van der Donk WA.

ACS Chem Biol. 2014 Mar 21;9(3):796-801. doi: 10.1021/cb4008106. Epub 2014 Jan 17.

5.

The glycosyltransferase involved in thurandacin biosynthesis catalyzes both O- and S-glycosylation.

Wang H, Oman TJ, Zhang R, Garcia De Gonzalo CV, Zhang Q, van der Donk WA.

J Am Chem Soc. 2014 Jan 8;136(1):84-7. doi: 10.1021/ja411159k. Epub 2013 Dec 16.

6.

Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation.

Knerr PJ, Oman TJ, Garcia De Gonzalo CV, Lupoli TJ, Walker S, van der Donk WA.

ACS Chem Biol. 2012 Nov 16;7(11):1791-5. doi: 10.1021/cb300372b. Epub 2012 Sep 4.

Supplemental Content

Loading ...
Support Center